151 related articles for article (PubMed ID: 1977518)
1. Tumor progression in four mammary epithelial cell lines derived from the same patient.
Band V; Zajchowski D; Swisshelm K; Trask D; Kulesa V; Cohen C; Connolly J; Sager R
Cancer Res; 1990 Nov; 50(22):7351-7. PubMed ID: 1977518
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
Ram TG; Ethier SP
Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP
Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535
[TBL] [Abstract][Full Text] [Related]
4. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media.
Ethier SP; Mahacek ML; Gullick WJ; Frank TS; Weber BL
Cancer Res; 1993 Feb; 53(3):627-35. PubMed ID: 8425198
[TBL] [Abstract][Full Text] [Related]
5. Isolation of two distinct epithelial cell lines from a single feline mammary carcinoma with different tumorigenic potential in nude mice and expressing different levels of epidermal growth factor receptors.
Minke JM; Schuuring E; van den Berghe R; Stolwijk JA; Boonstra J; Cornelisse C; Hilkens J; Misdorp W
Cancer Res; 1991 Aug; 51(15):4028-37. PubMed ID: 1649697
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.
Tuck AB; Arsenault DM; O'Malley FP; Hota C; Ling MC; Wilson SM; Chambers AF
Oncogene; 1999 Jul; 18(29):4237-46. PubMed ID: 10435636
[TBL] [Abstract][Full Text] [Related]
7. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
Ethier SP; Kokeny KE; Ridings JW; Dilts CA
Cancer Res; 1996 Feb; 56(4):899-907. PubMed ID: 8631031
[TBL] [Abstract][Full Text] [Related]
8. Expression of growth factors and oncogenes in normal and tumor-derived human mammary epithelial cells.
Zajchowski D; Band V; Pauzie N; Tager A; Stampfer M; Sager R
Cancer Res; 1988 Dec; 48(24 Pt 1):7041-7. PubMed ID: 3191480
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
10. Expression of estrogen receptors in estrogen receptor-negative human breast carcinoma cells: modulation of epidermal growth factor-receptor (EGF-R) and transforming growth factor alpha (TGF alpha) gene expression.
Sheikh MS; Shao ZM; Chen JC; Li XS; Hussain A; Fontana JA
J Cell Biochem; 1994 Mar; 54(3):289-98. PubMed ID: 8200909
[TBL] [Abstract][Full Text] [Related]
11. Differential tumorigenicity of two autologous human breast carcinoma cell lines, HMT-3909S1 and HMT-3909S8, established in serum-free medium.
Petersen OW; van Deurs B; Nielsen KV; Madsen MW; Laursen I; Balslev I; Briand P
Cancer Res; 1990 Feb; 50(4):1257-70. PubMed ID: 2153455
[TBL] [Abstract][Full Text] [Related]
12. Blockage of EGF receptor signal transduction causes reversible arrest of normal and immortal human mammary epithelial cells with synchronous reentry into the cell cycle.
Stampfer MR; Pan CH; Hosoda J; Bartholomew J; Mendelsohn J; Yaswen P
Exp Cell Res; 1993 Sep; 208(1):175-88. PubMed ID: 7689475
[TBL] [Abstract][Full Text] [Related]
13. Human breast carcinoma cell lines: ultrastructural, genotypic, and immunocytochemical characterization.
Mehta RR; Bratescu L; Graves JM; Hart GD; Shilkaitis A; Green A; Beattie CW; Das Gupta TK
Anticancer Res; 1992; 12(3):683-92. PubMed ID: 1377894
[TBL] [Abstract][Full Text] [Related]
14. Altered gene expression in drug-resistant human breast cancer cells.
Wosikowski K; Schuurhuis D; Kops GJ; Saceda M; Bates SE
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2405-14. PubMed ID: 9815641
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of the c-kit and stem cell factor genes in breast carcinomas.
Hines SJ; Organ C; Kornstein MJ; Krystal GW
Cell Growth Differ; 1995 Jun; 6(6):769-79. PubMed ID: 7545433
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
Liu L; Gudas LJ
J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002
[TBL] [Abstract][Full Text] [Related]
17. A functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin.
Berquin IM; Dziubinski ML; Nolan GP; Ethier SP
Oncogene; 2001 Jul; 20(30):4019-28. PubMed ID: 11494130
[TBL] [Abstract][Full Text] [Related]
18. Pyruvate utilization, phosphocholine and adenosine triphosphate (ATP) are markers of human breast tumor progression: a 31P- and 13C-nuclear magnetic resonance (NMR) spectroscopy study.
Singer S; Souza K; Thilly WG
Cancer Res; 1995 Nov; 55(22):5140-5. PubMed ID: 7585561
[TBL] [Abstract][Full Text] [Related]
19. Distinct karyotypes in three breast cancer cell lines --21PTCi, 21NTCi, and 21MT-1 --derived from the same patient and representing different stages of tumor progression.
Xu J; Souter LH; Chambers AF; Rodenhiser DI; Tuck AB
Cancer Genet Cytogenet; 2008 Oct; 186(1):33-40. PubMed ID: 18786440
[TBL] [Abstract][Full Text] [Related]
20. Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors.
Bacus SS; Gudkov AV; Zelnick CR; Chin D; Stern R; Stancovski I; Peles E; Ben-Baruch N; Farbstein H; Lupu R
Cancer Res; 1993 Nov; 53(21):5251-61. PubMed ID: 8106145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
